Latest news for Curative Biotechnology (OTC:CUBT) Stock

Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.

CURATIVE BIOTECHNOLOGY by CURATIVE BIOTECHNOLOGY INC.

Curative Biotechnology Inc

Garmin (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grmn#NYSE">GRMN</a>) launched the JL Audio MediaMaster&nbsp;55 and 55-HR next-generation marine and powersports source units.
The MM55 features a 2.8-inch full-color LCD display with larger icons, simplified menus and a refreshed color palette, while the MM55-HR is a versatile helm device that can be mounted in various areas around a boat or vehicle, enhancing its efficiency.
These devices also offer connectivity options like digital AM/FM tuner, DAB+ radio, Bluetooth, analog AUX input and USB connection. With advanced Bluetooth Low Energy technology, users can control the devices using the MediaMaster Remote App or a compatible multifunction display.
Garmin is expected to gain solid traction across anglers, sailors, mariners and boat owners on the back of its newly launched devices.
<div class="chart_embed">
<h3>Garmin Ltd. Price and Consensus</h3>
<img alt="Garmin Ltd. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/9d/1721223059.png" style="height:281px; width:620px" title="" />
Garmin Ltd. price-consensus-chart | Garmin Ltd. Quote
</div>
<h3>Expanding Marine Portfolio Aid Prospects</h3>
Per a Skyquest report, the global marine electronics market is expected to reach $8.13 billion by 2030, witnessing a CAGR of 5.2% between 2023 and 2030. Garmin is well-positioned to capitalize on this solid growth opportunity on the back of its expanding marine offerings.
Recently, the company introduced the Panoptix PS22-IF Ice Fishing Bundle, a live sonar solution for hardwater anglers. The bundle features an ECHOMAP UHD2 73sv touchscreen combo and two Panoptix sonar modes for ice fishing.
Garmin introduced the Force Kraken trolling motor series, available with a 48-inch shaft length for smaller boat sizes. Its wireless integration with Garmin chartplotters and smartwatches allows for easy route creation and installation of live sonar. Anglers can navigate from anywhere with the included wireless remote, and a compatible Garmin smartwatch can be connected for control.
It also expanded its GPSMAP x3 family with the introduction of GPSMAP 16x3 chartplotters. These chartplotters boast a high-resolution 16-inch touchscreen display with built-in navigation and sonar support, offering superior clarity and sunlight readability, even with polarized sunglasses.
<h3>Portfolio Strength: Key Catalyst</h3>
Garmin shares have rallied 36.5% in the year-to-date period, outperforming the industry&#39;s growth of 13.9%. The company has been riding on its portfolio strength. Hence, expanding marine offerings bodes well for its overall portfolio strength.
Garmin recently added two slimline radios to the GTR 205 COMM radio series for the experimental aviation market. The newly launched GTR 205x and GTR 205xR are all-in-one radios and stereo intercoms with Bluetooth functionality for phone calls and media entertainment. Pilots can stream music, receive calls, view phone numbers, and see device strength and battery life on the panel-mount version.
It expanded its outdoor offerings with the launch of a laser range finder, Approach Z30, to deliver an enhanced experience to golfers with its advanced ranging performance and Range Relay feature.
Garmin also partnered with Alphabet&#39;s Google to bolster its smartwatch offerings.
Per the terms, Alphabet&#39;s YouTube Music app is now available on Garmin IQ Connect smartwatches, allowing users to add playlists and podcasts to their devices.
A strengthening portfolio is expected to continue driving Garmin&#39;s overall financial performance in the upcoming period.
For 2024, Garmin expects total revenues of $5.75 billion. The Zacks Consensus Estimate for 2024 total revenues stands at $5.90 billion, indicating year-over-year growth of 12.9%.
It expects 2024 earnings at $5.40 per share. The consensus mark for 2024 earnings is pegged at $5.77 per share, indicating a 3.2% rise from the year-ago figure. The figure has been revised upward by 0.5% in the past 60 days.
<h3>Zacks Rank &amp; Other Stocks to Consider</h3>
Currently, Garmin carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader technology sector are PayPal (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pypl#NASDAQ">PYPL</a>) and Badger Meter (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmi#NYSE">BMI</a>), each sporting a Zacks Rank #1 (Strong Buy) at present.
PayPal shares have gained 0.7% in the year-to-date period. The long-term earnings growth rate for PYPL is 14.79%.
Badger Meter shares have gained 27% in the year-to-date period. The long-term earnings growth rate for BMI is currently projected at 15.57%.
<a href="https://www.zacks.com/stock/news/2303697/garmin-grmn-expands-marine-portfolio-with-mm55-55-hr-devices?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2303697">To read this article on Zacks.com click here.</a>

Earnings

News

Markets

Analyst Ratings

Tech

Trading Ideas

GRMN

PYPL

Garmin Expands Marine Portfolio With MM55 & 55-HR Devices

Former White House Communications Director and current CEO of SkyBridge Capital Anthony Scaramucci publicly criticized the Democrats for their handling <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/39004550/exclusive-all-you-need-to-know-about-the-fit21-crypto-bill">of cryptocurrency legislation</a>. 
What Happened: Scaramucci, who served under the Trump administration in 2017, expressed his disappointment with the Democrats' failure to enact clear crypto legislation in an exclusive <a href="https://www.coindesk.com/policy/2024/07/17/democrats-have-made-a-horrific-mistake-says-skybridge-capitals-anthony-scaramucci/?_gl=1&#x2A;ksqxmv&#x2A;_up&#x2A;MQ..&#x2A;_ga&#x2A;MTg3NjA4Mjk2NC4xNzIxMjMwNDQ3&#x2A;_ga_VM3STRYVN8&#x2A;MTcyMTIzMDQ0Ni4xLjAuMTcyMTIzMDQ0Ni4wLjAuMjA5MDYxODIwMg">interview</a> with CoinDesk. "The Democrats have made a horrific mistake," he said. "They could have been neutral on crypto or positive on crypto. And I think it would have helped them in the election."
Despite his criticism, Scaramucci continues to support the Democrats. However, he voiced his disapproval of SEC Chair Gary Gensler, calling for his dismissal. He argued that Gensler and Sen. Elizabeth Warren's (D-Mass.) antipathy has been an "unbelievable disaster" for the crypto industry.
Scaramucci also shared his views on Trump&#8217;s pro-crypto stance, stating that if reelected, which has a 70% probability on crypto prediction market Polymarket, the new administration would create a supportive environment for the crypto industry. However, he clarified that while he appreciates Trump&#8217;s pro-crypto position, he is not a "one issue voter."
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39717014/is-a-donald-trump-presidency-the-next-big-catalyst-for-bitcoin">Is A Donald Trump Presidency The Next Big Catalyst For Bitcoin?</a>
Why It Matters: The Democrats&#8217; stance on cryptocurrency has been a contentious issue. Their failure to enact clear legislation has led to uncertainty and instability in the crypto market.
Scaramucci's criticism highlights the need for clear and supportive crypto legislation to foster growth and innovation in the industry. His comments also underscore the political implications of the crypto debate, suggesting that a more positive stance on crypto could have electoral benefits.
He concluded that he sees himself having "Trump reality syndrome" and Trump lacking intellectual curiosity. He added, "these think tanks that are working alongside of him want to build his transition into the first few years of his presidency as a dystopian."
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39817200/donald-trump-comments-on-crypto-pivot-if-we-dont-do-it-china-will">Donald Trump Comments On Crypto Pivot: &#8216;If We Don&#8217;t Do It, China Will&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Anthony Scaramucci Will Not Vote For Donald Trump Despite The Latter's Crypto Pivot: Report

TD Cowen analyst Andrew Charles maintains Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) with a Hold and lowers the price target from $19 to $17.

Price Target

TD Cowen Maintains Hold on Wendy's, Lowers Price Target to $17

Vale S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vale#NYSE">VALE</a>) reported iron ore production of 80.6 million tons (Mt) for the second quarter of 2024, which was up 2% year over year, attributed to improved operating performance at the S11D and Vargem Grande.
During the quarter, the S11D mine delivered record production of 19.5 Mt, bolstered by ongoing asset reliability initiatives.
Pellet production declined 2.4% year over year to 8.9 Mt. This was attributed to lower pellet feed availability at the Vargem Grande plant and maintenance at the S&atilde;o Luis plant.
Iron ore fines sales improved 8.2% from the year-ago quarter to 68.5 Mt while pellet sales were up 0.6% to around 8.9 Mt. Total iron ore sales were up 7.3% to 79.8 Mt, reflecting higher shipments, as well as the sale of inventories from prior periods.
The average realized iron ore fines price was $98.2 per ton in the June-ended quarter, down 0.3% year over year and 2.5% sequentially, due to lower iron ore prices.
<h3>Copper Output Dips, Nickel Plunges</h3>
In the second quarter, Vale produced 78.6 kt of copper, which was 0.3% lower than the year-ago quarter. Improved productivity at Salobo&#39;s 1 &amp; 2 plants, as well as Sossego, were offset by the bi-annual maintenance in Sudbury.&nbsp;
Vale sold 76.1 kt of copper, which was up 3% from the year-ago quarter, reflecting sales from its inventory despite lower production.&nbsp;
The average realized price for copper operations only (Salobo and Sossego) was $9,202 per ton, up 31% year over year and 19.7% on a sequential basis due to higher LME prices. The average realized copper price for all operations (including copper sales originating from nickel operations) was $9,187 per ton.
Production of nickel plunged 24% year over year to 27.9 kt in the April-June 2024 period. This reflects the impact of the planned maintenance strategy at the nickel processing plants.&nbsp;
Nickel sales were recorded at 34.3 kt, down 15% from the year-ago comparable quarter&#39;s figure due to lower production figures. The average realized nickel price was $18,638 per ton, down 19% compared with $23,070 per ton in the year-ago quarter. This was in line with the decrease in LME nickel reference prices.
<h3>Guidance for 2024</h3>
The company&#39;s iron ore production guidance for 2024 is in the range of 310-320 Mt. Vale had produced 321 Mt of iron ore in 2023. Pellet production is projected to be between 38 Mt and 42 Mt, higher than the figure of 36.5 MT in 2023.
Vale expects to produce copper in the range of 320-355 kt. The company&#39;s copper output in 2023 was reported at 326.6 kt.
Vale expects nickel production to be between 160 kt and 175 kt. In 2023, the total production of nickel was recorded at 164.9 kt.
<h3>Peer Performances</h3>
Rio Tinto (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rio#NYSE">RIO</a>) reported a 2% decrease in its second-quarter (ended Jun 30, 2024) iron ore production to 79.5 MT (on a 100% basis) as ore depletion offset productivity gains. A train had derailed in mid-May at its Western Australia iron ore operations, which led to six days of lost rail capacity and full stockpiles at some mines, impacting production for the quarter. Copper production was 171 thousand tons, 18% higher than the year-ago quarter.
RIO&#39;s shipments for the quarter (on a 100% basis) were reported at 80.3 Mt, which were down 2% year over year. The company expects Pilbara iron ore shipments (100% basis) to be between 323 Mt and 338 Mt in 2024. The range indicates a year-over-year decline of 3% to growth of 2%.
BHP Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhp#NYSE">BHP</a>) announced that its iron ore production rose 6% year over year to 69.2 Mt in the fourth quarter of fiscal 2024 (ended Jun 30, 2024), aided by record production at Western Australia Iron Ore as a result of strong underlying performance at the mines and the benefits of the Port Debottlenecking Project 1. Copper output improved 6% year over year to 504.9 kt.&nbsp;
BHP&#39;s iron ore production for fiscal 2024 was a record 260 Mt and copper production was 1,865 kt, the highest in 15 years.
<h3>Price Performance</h3>
Shares of Vale have lost 18.1% in a year, in line with the industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/3d/71668.jpg?v=29781560" />
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; A Stock to Consider</h3>
Vale currently carries a Zacks Rank #3 (Hold).
A better-ranked stock in the Basic Materials space is Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), which currently sports a Zacks Rank #1 (Strong Buy).
The Zacks Consensus Estimate for Carpenter Technology&#39;s fiscal 2024 earnings indicates year-over-year growth of 281.6%. CRS beat the consensus estimate in each of the last four quarters, the average earnings surprise being 15.1%. The company&#39;s shares have soared 109% in the past year.
<a href="https://www.zacks.com/stock/news/2303694/vale-s-q2-iron-ore-output-up-2-y-y-copper-and-nickel-lags?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2303694">To read this article on Zacks.com click here.</a>

Guidance

Commodities

VALE

VALE's Q2 Iron Ore Output Up 2% Y/Y, Copper and Nickel Lags

Telsey Advisory Group analyst Joseph Feldman maintains Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) with a Outperform and lowers the price target from $155 to $120.

FIVE

Telsey Advisory Group Maintains Outperform on Five Below, Lowers Price Target to $120

Whales with a lot of money to spend have taken a noticeably bearish stance on Charter Communications.
Looking at options history for Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 10% of the investors opened trades with bullish expectations and 70% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $197,400 and 4, calls, for a total amount of $244,150.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $230.0 to $400.0 for Charter Communications over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Charter Communications options trades today is 496.86 with a total volume of 138.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Charter Communications's big money trades within a strike price range of $230.0 to $400.0 over the last 30 days.
<h3>Charter Communications Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721241058_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CHTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.0</td>
<td>$15.1</td>
<td>$16.0</td>
<td>$400.00</td>
<td>$160.0K</td>
<td>2.7K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CHTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$5.3</td>
<td>$5.0</td>
<td>$5.2</td>
<td>$230.00</td>
<td>$43.1K</td>
<td>237</td>
<td style="text-align: right;">54</td>
</tr>
<tr>
<td>CHTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.3</td>
<td>$4.4</td>
<td>$5.2</td>
<td>$230.00</td>
<td>$37.4K</td>
<td>237</td>
<td style="text-align: right;">54</td>
</tr>
<tr>
<td>CHTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$31.6</td>
<td>$30.6</td>
<td>$31.6</td>
<td>$330.00</td>
<td>$34.7K</td>
<td>10</td>
<td style="text-align: right;">40</td>
</tr>
<tr>
<td>CHTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$66.9</td>
<td>$63.0</td>
<td>$63.0</td>
<td>$350.00</td>
<td>$31.5K</td>
<td>94</td>
<td style="text-align: right;">3</td>
</tr>
</tbody>
</table>

<h3>About Charter Communications</h3>
Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 57 million US homes and businesses, around 40% of the country. Across this footprint, Charter serves 30 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest US cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.
After a thorough review of the options trading surrounding Charter Communications, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Charter Communications Standing Right Now?</h3>
<ul>
<li>With a volume of 765,007, the price of CHTR is up 0.97% at $330.58. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 9 days.</li>
</ul>
<h3>What The Experts Say On Charter Communications</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $252.5.
<ul>
<li>In a cautious move, an analyst from Goldman Sachs downgraded its rating to Sell, setting a price target of $250. </li>
<li>An analyst from Citigroup downgraded its action to Sell with a price target of $255. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Charter Communications with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

CHTR

Spotlight on Charter Communications: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Carnival.
Looking at options history for Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $333,649 and 9, calls, for a total amount of $287,330.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $17.0 to $35.0 for Carnival over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Carnival's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Carnival's significant trades, within a strike price range of $17.0 to $35.0, over the past month.
<h3>Carnival Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721241054_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$8.85</td>
<td>$8.75</td>
<td>$8.75</td>
<td>$27.00</td>
<td>$261.6K</td>
<td>312</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.02</td>
<td>$1.98</td>
<td>$1.99</td>
<td>$20.00</td>
<td>$47.3K</td>
<td>30.8K</td>
<td style="text-align: right;">548</td>
</tr>
<tr>
<td>CCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.25</td>
<td>$3.2</td>
<td>$3.2</td>
<td>$21.00</td>
<td>$39.6K</td>
<td>273</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$1.73</td>
<td>$1.7</td>
<td>$1.7</td>
<td>$17.00</td>
<td>$34.0K</td>
<td>24.0K</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>CCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/02/24</td>
<td>$0.16</td>
<td>$0.15</td>
<td>$0.16</td>
<td>$17.00</td>
<td>$32.3K</td>
<td>427</td>
<td style="text-align: right;">10</td>
</tr>
</tbody>
</table>

<h3>About Carnival</h3>
Carnival is the largest global cruise company, with 92 ships in service at the end of fiscal 2023. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&amp;O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It's currently folding its P&amp;O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted nearly 13 million guests in 2019, prior to covid-19, a level it reached again in 2023.
<h3>Where Is Carnival Standing Right Now?</h3>
<ul>
<li>With a trading volume of 19,040,582, the price of CCL is down by -3.65%, reaching $18.48.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 72 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Carnival</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $22.4.
<ul>
<li>An analyst from Citigroup has decided to maintain their Buy rating on Carnival, which currently sits at a price target of $22. </li>
<li>Consistent in their evaluation, an analyst from Deutsche Bank keeps a Hold rating on Carnival with a target price of $19. </li>
<li>An analyst from B of A Securities has decided to maintain their Buy rating on Carnival, which currently sits at a price target of $24. </li>
<li>Consistent in their evaluation, an analyst from Argus Research keeps a Buy rating on Carnival with a target price of $25. </li>
<li>Maintaining their stance, an analyst from Susquehanna continues to hold a Positive rating for Carnival, targeting a price of $22. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Carnival options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Carnival's Options Frenzy: What You Need to Know

Whales with a lot of money to spend have taken a noticeably bullish stance on KLA.
Looking at options history for KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) we detected 29 trades.
If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 31% with bearish.
From the overall spotted trades, 18 are puts, for a total amount of $1,066,035 and 11, calls, for a total amount of $523,769.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $680.0 to $1140.0 for KLA over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for KLA's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across KLA's significant trades, within a strike price range of $680.0 to $1140.0, over the past month.
<h3>KLA 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721241049_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$33.6</td>
<td>$27.6</td>
<td>$33.7</td>
<td>$830.00</td>
<td>$250.7K</td>
<td style="text-align: right;">126</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>KLAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$216.0</td>
<td>$210.0</td>
<td>$211.27</td>
<td>$700.00</td>
<td>$105.6K</td>
<td style="text-align: right;">16</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$36.6</td>
<td>$35.5</td>
<td>$35.5</td>
<td>$700.00</td>
<td>$71.0K</td>
<td style="text-align: right;">116</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>KLAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$26.4</td>
<td>$21.0</td>
<td>$23.4</td>
<td>$900.00</td>
<td>$70.2K</td>
<td style="text-align: right;">199</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/26/24</td>
<td>$75.0</td>
<td>$67.8</td>
<td>$70.15</td>
<td>$877.50</td>
<td>$70.1K</td>
<td style="text-align: right;">12</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About KLA</h3>
KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.
Following our analysis of the options activities associated with KLA, we pivot to a closer look at the company's own performance.
<h3>KLA's Current Market Status</h3>
<ul>
<li>Trading volume stands at 590,309, with KLAC's price down by -8.04%, positioned at $797.42.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 7 days.</li>
</ul>
<h3>Expert Opinions on KLA</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $935.0.
<ul>
<li>An analyst from Cantor Fitzgerald persists with their Neutral rating on KLA, maintaining a target price of $950. </li>
<li>Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on KLA with a target price of $875. </li>
<li>Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for KLA, targeting a price of $980. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest KLA options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

KLAC

Looking At KLA's Recent Unusual Options Activity

KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) has outperformed the market over the past 20 years by 7.85% on an annualized basis producing an average annual return of 16.37%. Currently, KLA has a market capitalization of $107.36 billion. 
Buying $100 In KLAC: If an investor had bought $100 of KLAC stock 20 years ago, it would be worth $2,057.33 today based on a price of $797.42 for KLAC at the time of writing.
<h3>KLA's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721241016_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In KLA 20 Years Ago Would Be Worth This Much Today

Owens-Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) has outperformed the market over the past 5 years by 12.96% on an annualized basis producing an average annual return of 26.14%. Currently, Owens-Corning has a market capitalization of $15.31 billion. 
Buying $100 In OC: If an investor had bought $100 of OC stock 5 years ago, it would be worth $323.06 today based on a price of $176.65 for OC at the time of writing.
<h3>Owens-Corning's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721241011_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Owens-Corning 5 Years Ago Would Be Worth Today

TD Cowen analyst Andrew Charles maintains Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with a Hold and lowers the price target from $85 to $81.

SBUX

TD Cowen Maintains Hold on Starbucks, Lowers Price Target to $81

TD Cowen analyst Andrew Charles maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Buy and lowers the price target from $305 to $285.

TD Cowen Maintains Buy on McDonald's, Lowers Price Target to $285

V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) shares are trading higher Wednesday after the company announced it entered into an agreement to sell its Supreme brand to EssilorLuxottica <a href="https://www.benzinga.com/markets/equities/24/07/39819517/why-apparel-company-vf-corp-shares-are-surging-today">for $1.5 billion in cash.</a>
The Details:
VF said it expects the sale of Supreme to be dilutive to its earnings per share in VF's 2025 fiscal year. Supreme contributed $538 million of revenue and $166 million in operating income during VF's 2024 fiscal year.
"Under VF, Supreme expanded its presence in the key markets of China and South Korea and has returned to delivering strong growth. However, given the brand's distinct business model and VF's integrated model, our strategic portfolio review concluded there are limited synergies between Supreme and VF, making a sale a natural next step," Bracken Darrell, CEO at VF, said in a <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000103379/000119312524179856/d871255d8k.htm">press release</a>.&nbsp;
Read Next:<a href="https://www.benzinga.com/news/24/07/39796841/lucids-stock-drives-higher-on-2025-model-year-updates-whats-going-on"> Lucid&#8217;s Stock Drives Higher On 2025 Model Year Updates: What&#8217;s Going On?</a>
VF Corporation shares are moving higher on above-average trading volume as investors digest the sale of the Supreme brand. The stock is climbing above its 50-day moving average of $13.17. 
VF Corp is set to report its first-quarter 2025 results on Aug. 6 after the closing bell. According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect the company to report losses of 37 cents per share and quarterly revenue of $1.85 billion.&nbsp;
<h2 class="wp-block-heading">Should I Sell My VFC Stock? </h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
VFC shares have lost 24.17% year to date. This compares to the average annual return of -40.25%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. VF stock currently has an RSI of 70.57, indicating overbought conditions.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a> 
VFC Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, VF Corporation shares are up 13.6% at $16.16 at the time of publication Wednesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39805320/what-happened-with-canopy-growth-stock-today">What Happened With Canopy Growth Stock Today?</a></li>
</ul>
Image: Shutterstock

Movers

What's Going On VF Corp Stock After Supreme Brand Sold For $1.5 Billion?

It&#8217;s deep red on Wall Street on Wednesday, with tech stocks sharply falling amid a semiconductor broad-based selloff following news that the Biden administration is hastening<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39821315/ai-earthquake-semiconductors-suffer-worst-selloff-in-years-on-stricter-us-chip-expo"> export restrictions to China. </a>
Bloomberg reported on Wednesday that the U.S. administration has advised its allies to impose the strictest trade restrictions possible if companies such as Tokyo Electron Ltd. (OTCPK: TOELY) and ASML Holding NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) persist in supplying advanced chips to China. Shares of the Dutch chipmaker ASML Holding fell nearly 12%, notching the worst decline since March 2020. 
The tech-heavy Nasdaq 100 tumbled by 2.7% at 12:45 p.m. ET, marking the worst session since late August 2023. The semiconductor industry was the hardest hit. The iShares Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NYSE">SOXX</a>) and the VanEck Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NYSE">SMH</a>) both plummeted over 6%, marking their worst day since October 2022.
The elite group of the &#8216;Magnificent Seven,&#8217; tracked by the Roundhill Magnificent Seven ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NASDAQ">MAGS</a>), saw a collective market cap loss of $500 billion in a single trading session. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) alone plummeted 7%, accounting for a $180 billion loss.
The S&amp;P 500 dropped 1.2%, while blue-chip stocks of the Dow Jones rose 0.6% to 41,200 points, extending their all-time highs and marking a sixth consecutive session of gains. Meanwhile, small caps took a breather, with the Russell 2000 index falling 1%, ending a five-day winning streak.
U.S. natural gas futures fell over 6%, hitting two-month lows, due to lower-than-expected cooling demand amid milder weather forecasts for the next two weeks.
Oil prices rallied 1.9% after U.S. inventories declined again last week. Gold edged down 0.5% from the all-time highs reached on Tuesday. The dollar fell 0.4%, with the dollar-yen pair dropping 1.3%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) eased 1.2%. 
<h3 class="wp-block-heading">Wednesday&#8217;s Performance In US Major Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % chg</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,154.73</td>
<td>0.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,240.18</td>
<td>-1.1%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,592.13</td>
<td>-1.3%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,862.83</td>
<td>-2.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:05 p.m. ET</figcaption></figure>
According to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071724&amp;t=be2bearmibe3na1">Benzinga Pro</a> data: 
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;was 1.4% lower to $557.02.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;rose by 0.4% to $411.20.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(ARCA:&nbsp;<a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a><a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a>QQQ) eased 2.7% to $482.82.</li>
<li>Sector-wise, the&nbsp;Consumer Staples Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)&nbsp;outperformed, up by 1.3%, while the&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down 3.6%.</li>
</ul>
<h3 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h3>
<ul>
<li>Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) tumbled 8.3%, dropping below the 50-day moving average support. </li>
<li>U.S.-listed shares of Taiwan Semiconductor Manufacturing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) plummeted 7% following reports that U.S. presidential candidate Donald Trump suggested Taiwan should compensate the U.S. for its defense.</li>
<li>British chipmaker Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) tumbled 8.7%.</li>
<li>Other chip giants, including Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) and Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), also saw declined by about 8%.</li>
<li>Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) rallied 3.7% on stronger-than-expected quarterly results. </li>
<li>Charles Schwab Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) plunged 9.4%, following a 10.2% drop on Tuesday, as several analysts lowered their price targets in response to disappointing Q2 earnings.</li>
<li>Other stocks reacting to company earnings were Elevance Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>), down 6.5%, U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>), up 4.6%, Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), down 3%, Northern Trust Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>), down 7%, Citizens Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>), up 3.4% and Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>), up 0.6%. </li>
<li>Companies reporting after the close include Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>), Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>), Kinder Morgan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>), SL Green Realty Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>), Steel Dynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) and United Airlines Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>).</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39819662/bank-of-america-analysts-stick-to-december-rate-cut-prediction-brace-for-election-f">Bank Of America Analysts Stick To December Rate Cut Prediction, Brace For Election-Fueled S&amp;P 500 Turbulence</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Large Cap

Sector ETFs

Econ #s

ETFs

ALLY

AMAT

ASML

SPDR Dow Jones Industrial Average ETF Trust

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

LRCX

MAGS

MRVL

NTRS

NVDA

SCHW

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

STLD

TOELY

Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday?

WIIM

ICHR

NTAP

PSTG

SMCI

VECO

Shares of hardware and data center companies are trading lower amid a selloff in chips and AI-related stocks.

The European Commission faced criticism from Europe&#8217;s second-highest court regarding transparency issues surrounding COVID-19 vaccine <a target="_blank" href="https://www.benzinga.com/general/biotech/23/03/31170243/european-commission-keeps-mum-on-talks-regarding-pfizer-covid-19-vaccine-contract-report" rel="noreferrer noopener">contracts from four years ago</a>.
This scrutiny comes on the eve of a crucial vote on Commission head Ursula von der Leyen&#8216;s reelection bid.
Some European lawmakers have been vocal about their dissatisfaction with how the Commission handled its multibillion-euro contracts, particularly its failure to disclose text messages between von der Leyen and Pfizer Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) CEO Albert Bourla regarding one of the agreements.
In 2022, a&nbsp;Pfizer executive &#8220;categorically&#8221; ruled out that the pharma giant&#8217;s chief executive agreed on the European COVID-19 contract via <a target="_blank" href="https://www.benzinga.com/general/biotech/22/10/29203684/pfizers-executive-says-european-covid-19-vaccine-contract-negotiations-did-not-happen-over-text-m" rel="noreferrer noopener">mobile phone text messages</a>.
The Commission contends that these messages were not retained.
During the height of the pandemic, the Commission secured agreements with several major companies for COVID vaccine supplies, including AstraZeneca Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>), Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>), GSK Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>), Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>), Pfizer, and Moderna Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39687792/emergent-biosolutions-and-johnson-johnson-resolve-claims-over-covid-19-vaccine-manufacturing" rel="noreferrer noopener">Emergent BioSolutions And Johnson &amp; Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing</a>.
In response to requests from some members of the European Parliament for full access to these documents, Reuters noted that the Commission provided only partial access, citing the need to protect commercial interests and the decision-making process through redactions.
&#8220;The Commission did not give the public sufficiently wide access to the purchase agreements for COVID-19 vaccines,&#8221; they said.
The General Court in Luxembourg upheld the lawmakers&#8217; challenge, although the Commission claimed partial success in defending certain contract clauses.
&#8220;In general, the Commission grants the widest possible public access to documents, in line with the principles of openness and transparency,&#8221; Reuters noted, citing the statement.
&#8220;In these cases, the Commission needed to strike a difficult balance between the right of the public, including MEPs (members of the European Parliament), to information, and the legal requirements emanating from the COVID-19 contracts themselves, which could result in claims for damages at the cost of taxpayers&#8217; money.&#8221;
Meanwhile, the European Parliament is scheduled to vote on Thursday regarding von der Leyen&#8217;s candidacy for a second term amid ongoing scrutiny and legal challenges concerning transparency issues.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39602190/london-high-court-ruling-fuels-pfizer-and-moderna-legal-dispute-over-covid-19-vaccine-patents" target="_blank" rel="noreferrer noopener">London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents</a>.</li>
</ul>
Photo via Wikimedia Commons

Biotech

Eurozone

Health Care

Legal

General

BNTX

MRNA

European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment

Wednesday, 4D Molecular Therapeutics, Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) unveiled interim 24-week data from the Population Extension cohort of its PRISM <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/g39810122/4dmt-announces-positive-phase-2-prism-interim-results-for-intravitreal-4d-150-in-a-broad-wet-amd-p" rel="noreferrer noopener">Phase 2 Clinical Trial</a>.
The trial evaluates intravitreal 4D-150 in a broad wet AMD patient population.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/06/39211736/why-is-4d-molecular-therapeutics-stock-trading-lower-on-thursday-genetic-disease-focused-study-da" rel="noreferrer noopener">Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released</a>.
The findings were presented at the American Society of Retina Specialists Annual Scientific Meeting.
The Phase 2 PRISM Population Extension cohort evaluated 45 wet AMD patients previously treated with anti-VEGF injections, with 30 patients at 3E10 vg/eye (the planned Phase 3 dose) and 15 at 1E10 vg/eye (the low dose control).
In the expanded Phase 2 dataset, 4D-150 allowed 77% of 30 patients to become injection-free after 24 weeks, with 60% on low-dose arm.
An anti-VEGF treatment reduction was observed at the planned Phase 3 dose (3E10 vg/eye), with an 89% reduction in the mean annualized injection rate and 93% receiving 0 or 1 injection.
The data also showed improved visual acuity and retina anatomic outcomes.
The study reported no significant inflammation or 4D 150–related serious adverse events.
Long-term follow-up of Phase 1 patients treated with 4D-150 indicated stable visual acuity and retinal thickness over two years.
4D-150 demonstrated safety and efficacy in the PRISM (wet AMD) and SPECTRA (DME) clinical trials.
No significant inflammation or serious adverse events were reported among 139 dosed patients across both trials.
Upcoming milestones include the final Phase 3 trial design update in September 2024 and the initiation of the first Phase 3 trial in the first quarter of 2025.
Further analyses from the PRISM and SPECTRA studies are expected in early 2025.
Price Action: FDMT shares are down 35.7% at $17.19 at last check Wednesday. During the premarket session, shares reached as high as $29.1.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/03/37991496/4d-molecular-therapeutics-outlines-pivotal-development-plans-for-cystic-fibrosis-rare-inherited-d" target="_blank" rel="noreferrer noopener">4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease</a>.</li>
</ul>

FDMT

4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate

CFRA analyst Angelo Zino maintains Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Buy and raises the price target from $240 to $260.

AAPL

CFRA Maintains Buy on Apple, Raises Price Target to $260

Cantor Fitzgerald analyst Brett Knoblauch initiated coverage on Core Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>), <a target="_blank" href="https://www.benzinga.com/quote/CORZ/analyst-ratings" rel="noreferrer noopener">with a price forecast of $20.</a>
According to the analyst, Bitcoin miners currently have one of the most coveted assets in the world &#8211; access to power.
In June 2024, Core Scientific announced a deal with CoreWeave (private), following which<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener"> shares went up meaningfully.</a>
With CoreWeave, Core Scientific was the first Bitcoin miner to sign a meaningful AI/HPC deal.
In what has now been extended, CoreWeave will lease 270 MW from Core Scientific for 12 years, and pay the company a total of $4.725 billion over that duration, amounting to ~$1.45 million per MW.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/07/39716492/block-and-core-scientific-enter-supply-agreement-for-mining-asics" rel="noreferrer noopener">Block and Core Scientific Enter Supply Agreement for Mining ASICs</a>
What is most differentiated about this deal that other miners will not be able to replicate is the fact that CoreWeave will fund the entire capex buildout itself (~$1.3 billion).
Per the analyst, this is effectively an interest-free loan for CoreWeave, which can use the annuity like revenue stream to fund additional capacity expansion, and to potentially lever up the business to maximize equity returns.
Core Scientific has earmarked an additional 322 MW for AI/HPC, which could generate an additional $335 million in <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">annual revenue and $268 million in annual profits.</a>
Long term – the analyst sees the potential for shares to be multiples higher than the current price target.
Price Action: CORZ shares are trading lower by 5.17% to $11.10 at last check Wednesday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39749573/nio-advances-vehicle-safety-with-ai-enhanced-automatic-emergency-braking-and-navigation-features" target="_blank" rel="noreferrer noopener">NIO Advances Vehicle Safety With AI-Enhanced Automatic Emergency Braking And Navigation Features In Latest Update</a></li>
</ul>

Analyst Color

Initiation

Core Scientific, Inc. - Class A Common Stock

CORZ

Core Scientific Analyst Emphasizes 'Access To Power' In Bitcoin Mining Assets - Deal With CoreWeave Under Focus

Cassava Sciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) stock is trading lower on Wednesday on a heavy session volume of 14.35 million, as per data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
The Board of Directors appointed Richard (Rick) Barry as Executive Chairman and the company&#8217;s principal executive officer, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/g39813058/cassava-sciences-announces-changes-in-executive-leadership-enhanced-corporate-governance-and-other" rel="noreferrer noopener">effective immediately</a>. The company is searching for a new permanent CEO.
Mr. Barry succeeds Remi Barbier, the Company&#8217;s Chairman, President, and CEO, who resigned and will remain employed by the Company until September 13, 2024, in a non-executive capacity, without duties or responsibilities.
Lindsay Burns, SVP of Neuroscience at Cassava, is also leaving the company. Cassava and Dr. Burns have agreed that she step down from her role with the company, effective immediately.
Following her separation from the company and for a one-year period, Dr. Burns will furnish consulting services as and to the extent reasonably requested by Cassava to provide information and support for scientific research and/or obtain governmental approval for the company&#8217;s products.
Cassava may, at its sole discretion, extend the term of the consulting agreement by up to an additional year.
Related: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39578081/cassava-sciences-cooperates-with-doj-sec-on-controversial-alzheimers-drug-investigation" rel="noreferrer noopener">Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer&#8217;s Drug Investigation</a>.
Mr. Barry said. &#8220;While our priority remains the development of a potentially effective treatment for Alzheimer&#8217;s disease, the Board has a steadfast commitment to doing so with transparency, accountability, and highest ethical business practices.&#8221; Among the actions the company is taking are:
<ul>
<li>New Leadership: The Board plans to separate the Chairman and CEO roles after identifying a new CEO.</li>
<li>Single-minded Commitment to Scientific Rigor and Honest Transparency: The company&#8217;s mission is to evaluate simufilam as a groundbreaking Alzheimer&#8217;s treatment, focusing on scientific rigor and transparency with patients, government agencies, and investors. All study results will be promptly and accurately posted on <a href="https://www.globenewswire.com/Tracker?data=vZZ6OkMSOaios8h0rajvwWFmEyTvQ8IToK5KGykCu4U97tT9zTPV9sYfj4rz1dS4u4NUT6tyetMZxzwISZ444PosvJOTncWJZySdB_IktB8=" target="_blank" rel="noreferrer noopener">clinicaltrials.gov</a>.</li>
<li>Rigorous Clinical Trials:  The ongoing Phase 3 trials adhere to FDA and industry standards to ensure the integrity of results. Under the FDA-reviewed protocols, no company personnel know or will know which subjects receive the drug or placebo.</li>
<li>Blinding information is maintained by a small group at CRO, Premier Research. Additionally, company personnel do not have access to sub-study results or other data that could reveal which patients are on placebo.</li>
<li>All data is sent directly to Premier Research. Statistical analyses are conducted by professional biostatisticians at Pentara Corporation, with trial results transmitted to them independently by the CRO, without company involvement.</li>
<li>Transparency in Communications and Reporting: Cassava is dedicated to maintaining transparent communication with its stakeholders. The company will resume quarterly analyst calls and ensure management is accessible to journalists. Cassava is also reviewing its disclosure practices to provide clear, comprehensive information. Ongoing dialogues with shareholders, employees, customers, regulators, and the community will shape the company&#8217;s governance practices.</li>
</ul>
Price Action: SAVA shares are down 27.20% at $9.85 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/03/37605163/alzheimers-drug-trial-results-questioned-after-damning-fda-inspection-report" target="_blank" rel="noreferrer noopener">Alzheimer&#8217;s Drug Trial Results Questioned After &#8216;Damning&#8217; FDA Inspection Report</a>.</li>
</ul>